Inflammatory Bowel Disease Market is Expected to Surge due to Advancements in Biologics Therapeutics
Inflammatory bowel disease (IBD) refers to two chronic inflammatory conditions of the digestive tract known as ulcerative colitis and Crohn's disease. The diseases are characterized by abdominal pain, diarrhea, and gastrointestinal bleeding. Biologics have emerged as an effective therapeutic option for controlling and managing the inflammatory response in IBD patients.The Global Inflammatory...
0 Commenti 0 condivisioni 87 Views 0 Anteprima